Angeles Alvarez Secord, MD, MHSc

Angeles Alvarez Secord, MD, MHSc, discusses key takeaways from the PICCOLO trial.

Angeles Alvarez Secord, MD, discusses the key takeaways on the role of PARP inhibitors in ovarian cancer, based on data presented for 3 PARP inhibitors, olaparib, rucaparib, and niraparib.